General Announcement::Corrigenda - Corporate Governance Reports 2022 and 2023

Issuer & Securities

Issuer/ Manager
IX BIOPHARMA LTD.
Securities
IX BIOPHARMA LTD. - SG1BD9000009 - 42C
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
04-Oct-2023 19:44:44
Status
New
Announcement Sub Title
Corrigenda - Corporate Governance Reports 2022 and 2023
Announcement Reference
SG231004OTHRQ4PO
Submitted By (Co./ Ind. Name)
Gwendolin Lee Soo Fern
Designation
Company Secretary
Description (Please provide a detailed description of the event in the box below)

Please see attached.

Attachments

CG2022 and CG2023 - Corrigenda.pdf
Total size =128K